hotspot -WSS

hotspot

author：fashion 2025-09-06 04:15:07 - browse：7579

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Malaria cases in Florida and Texas: Here’s what you need to know

WSS

BD to buy Edwards patient monitoring unit for $4.2 billion

How one medical school became remarkably diverse

Data don't support strong claims for Covid

Trump demands the U.S. pay no more for drugs than other countries … again

Hepatitis C has a cure — but many Americans still lack access to it

An outdated Medicare rule harms dementia patients with anxiety

leisure time

hotspot

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

An outdated Medicare rule harms dementia patients with anxiety

In age of alternative facts, a scholarly course on calling out crap

Guidelines to prevent youth baseball injuries need more muscle

Supreme Court strikes down use of affirmative action

Medicare Advantage's lean provider networks lead CMS complaints

Drug repurposing or repositioning? The language matters

Tori Bowie and the unacceptable rates of Black maternal death

What does generative AI mean for health care? We asked experts

Medicare proposal to cover medical devices draws a mixed reaction

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

'Little Tech' descents on D.C., wanting a say in how AI is regulated

'Little Tech' descents on D.C., wanting a say in how AI is regulated

ASCO Daily Recap: CAR

How CO2 helps viruses stay alive longer in the air

FDA approves Moderna’s RSV vaccine, its second licensed product

hotspot

leisure time

knowledge

explore